Literature DB >> 7873594

Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo.

M Portero-Otin1, R H Nagaraj, V M Monnier.   

Abstract

Pyrraline (epsilon-2-(formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine) is an advanced Maillard reaction product formed from 3-deoxyglucosone in the non-enzymatic reaction between glucose and the epsilon-amino group of lysine residues on proteins. Although its presence in vivo as well as in in vitro incubations of proteins with sugars has been documented by immunochemical methods using polyclonal and monoclonal antibodies, its formation in proteins has recently been questioned by similar methodology. To clarify this issue, we investigated pyrraline formation in proteins following alkaline hydrolysis and quantitation by high-performance liquid chromatography on a C18 reverse-phase column. Time- and sugar concentration-dependent increase in pyrraline formation was noted in serum albumin incubated with either 100 mM glucose or 50 mM 3-deoxyglucosone. Formation of pyrraline from 3-deoxyglucosone was rapid at slightly acidic pH, confirming its synthetic pathway through this Maillard reaction intermediate. Low levels of pyrraline (< 10 pmol/mg protein) were also detected in a pool of human skin collagen by this method, but no age effect was apparent. Using a slightly different approach, pyrraline-like material was detected in human plasma proteins following enzyme digestion and analysis by high performance liquid chromatography. Plasma from diabetic patients showed a significant increase in pyrraline-like material compared to controls. The levels in diabetic and normal individuals were 21.6 +/- 9.56 and 12.8 +/- 5.6 pmol per mg protein, respectively (P = 0.005), reflecting thereby the elevated levels of the immediate precursor of pyrraline, 3-deoxyglucosone, in diabetic plasma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7873594     DOI: 10.1016/0167-4838(94)00209-y

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  The role of glycation cross-links in diabetic vascular stiffening.

Authors:  T J Sims; L M Rasmussen; H Oxlund; A J Bailey
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

Review 2.  Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication.

Authors:  H Younus; S Anwar
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

Review 3.  Pathways of the Maillard reaction under physiological conditions.

Authors:  Christian Henning; Marcus A Glomb
Journal:  Glycoconj J       Date:  2016-06-13       Impact factor: 2.916

4.  Plasma protein glycation in Alzheimer's disease.

Authors:  S Riviere; I Birlouez-Aragon; B Vellas
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

5.  Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.

Authors:  Naila Ahmed; Ognian K Argirov; Harjit S Minhas; Carlos A A Cordeiro; Paul J Thornalley
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

6.  Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Authors:  K Horie; T Miyata; K Maeda; S Miyata; S Sugiyama; H Sakai; C van Ypersole de Strihou; V M Monnier; J L Witztum; K Kurokawa
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

8.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

Review 9.  The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin.

Authors:  Peter S Spencer; Xiao Chen
Journal:  Toxics       Date:  2021-04-29

10.  Highland Barley and Its By-Products Enriched with Phenolic Compounds for Inhibition of Pyrraline Formation by Scavenging α-Dicarbonyl Compounds.

Authors:  Dianwei Zhang; Pei Zhu; Luxuan Han; Xiaomo Chen; Huilin Liu; Baoguo Sun
Journal:  Foods       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.